Douglas R Cary

2PUBLICATIONS
8CO-AUTHORS
Molecular targetsMedical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 14, 2026
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer Drug.

|Mar 31, 2017
Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.

Masahiro Ito, Toshio Tanaka, Douglas R Cary

Pageof 1

Frequent Collaborators

2 joint publications

Masahiro Ito

1 joint publications

Yusuke Kamada

1 joint publications

Kenichiro Shimokawa

1 joint publications

Jun Fujimoto